Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
Current Hematologic Malignancy Reports - United States
doi 10.1007/s11899-011-0093-y
Full Text
Open PDFAbstract
Available in full text
Date
June 11, 2011
Authors
Publisher
Springer Science and Business Media LLC